These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 652796)

  • 1. Estimation of plasma half-lives of vasopressin analogs from vasopressor responses by curve-fitting.
    Gazis D; Sawyer WH
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):584-9. PubMed ID: 652796
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma half-lives of vasopressin and oxytocin analogs after iv injection in rats.
    Gazis D
    Proc Soc Exp Biol Med; 1978 Sep; 158(4):663-5. PubMed ID: 693485
    [No Abstract]   [Full Text] [Related]  

  • 3. A bivariate radioimmunoassay for arginine vasopressin and the synthetic antidiuretic agent 1-deamino-8-D-arginine vasopressin (desmopressin).
    Sadler WA; Lynskey CP; Dawson KP
    Anal Biochem; 1984 Dec; 143(2):272-82. PubMed ID: 6532243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.
    Lundin S; Melin P; Vilhardt H
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):179-83. PubMed ID: 3969814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid phase synthesis and some pharmacological properties of 8-D-homoarginine-vasopressin and 1-deamino-8-D-homoarginine-vasopressin.
    Gunnar E; Lindeberg G; Melin P; Larsson LE
    Int J Pept Protein Res; 1976; 8(2):193-8. PubMed ID: 1270191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin.
    Manning M; Lowbridge J; Stier CT; Haldar J; Sawyer WH
    J Med Chem; 1977 Sep; 20(9):1228-30. PubMed ID: 926126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of vasopressin in hypertension: Cause or effect?
    Padfield PL; Brown JJ; Lever AF; Morton JJ; Robertson JI
    Lancet; 1976 Jun; 1(7972):1255-7. PubMed ID: 73691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tritiation of vasopressin analogues and their metabolic fate after intravenous injection in the rat.
    Janáky T; László FA; Morgat JL
    Acta Med Hung; 1984; 41(1):43-54. PubMed ID: 6739223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo apparent peptide-receptor dissociation rate constants for arginine vasopressin analogs estimated from inhibition of rat pressor responses.
    Gazis D
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2099-103. PubMed ID: 2827873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and malignant deoxycorticosterone hypertension in rats.
    Möhring J; Möhring B; Petri M; Haack D
    Clin Sci Mol Med Suppl; 1976 Dec; 3():45s-48s. PubMed ID: 1071663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular depression and stabilization by central vasopressin in rats.
    Imai Y; Abe K; Sasaki S; Minami N; Munakata M; Sakuma H; Hashimoto J; Nobunaga T; Sekino H; Yoshinaga K
    Hypertension; 1990 Mar; 15(3):291-300. PubMed ID: 2303287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),4-valine,-8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin.
    Lowbridge J; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Mar; 21(3):313-5. PubMed ID: 628009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats.
    Skopková J; Hrbas R; Barth T
    Endocrinol Exp; 1981; 15(2):129-38. PubMed ID: 6973460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of infusions of arginine vasopressin or 1-deamino-8-D-arginine vasopressin on common carotid vascular resistance in conscious, Long Evans rats.
    Gardiner SM; Compton AM; Bennett T
    Br J Pharmacol; 1989 May; 97(1):153-7. PubMed ID: 2720303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states.
    Morton JJ; Padfield PL; Forsling ML
    J Endocrinol; 1975 Jun; 65(3):411-24. PubMed ID: 168297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.